TradingMarkets’ 7 Stocks You Need To Know About Today
Astrazeneca’s
(
AZN |
Quote |
Chart |
News |
PowerRating) Crestor may have serious side effects,
according to the American Heart Association.
Genentech (DNA)
said that Phase III data showed that its drug Lucentis maintained or
improved vision in patients with macular degeneration.
Eyetech Pharmaceuticals
(
EYET |
Quote |
Chart |
News |
PowerRating) may be negatively impacted from
the Genentech news. The stock is down 35% pre-open.
Williams Sonoma
(
WSM |
Quote |
Chart |
News |
PowerRating) beat by 0.03. Q1 earnings rose 22%.
Dillard’s
(
DDS |
Quote |
Chart |
News |
PowerRating) missed by 0.04.
First Albany started TiVo
(
TIVO |
Quote |
Chart |
News |
PowerRating) with a buy.
The New York Times reports Guidant
(
GDT |
Quote |
Chart |
News |
PowerRating) knew of flaws with
its defibrillators